CLINDAHEXAL

This brand name is authorized in Germany, South Africa

Active ingredients

The drug CLINDAHEXAL contains one active pharmaceutical ingredient (API):

1 Clindamycin UNII T20OQ1YN1W - CLINDAMYCIN HYDROCHLORIDE

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. Read about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLINDAHEXAL Capsule	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FF01	Clindamycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02482500, 02482517, 02482523, 06963030, 06963047, 06963053, 06963076, 06963082, 07715110, 07715127
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/20.1.1/0038, 32/20.1.1/0039